Related Experiment Video
Updated: Aug 9, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation
Beatrice Eymin1, Paule Claverie, Caroline Salon
1INSERM U578, Groupe de Recherche sur le Cancer du Poumon, Université Joseph Fourier, La Tronche, France. Beatrice.Eymin@ujf-grenoble.fr
Abstract:
The Cdc25C phosphatase is a key regulator of mitotic entry which activity is tightly regulated by phosphorylation. In response to DNA damage, phosphorylation at serine 216 induces the cytosolic retention of Cdc25C through 14-3-3 binding. We previously reported the ability of the p14ARF tumor suppressor to induce the accumulation of inactive phospho-Cdc25C(Ser216) protein as well as a decrease of Cdc25C steady state level and correlated these events with a p53-independent G2 arrest. The aim of this study was to investigate the cellular signaling pathways involved in this process. By using specific pharmacological inhibitors, we demonstrate that activation of the ERK1/2 MAP kinases pathway is involved in the p53-independent G2 checkpoint induced by p14ARF Moreover, we show that activated P-ERK1/2 bind and phosphorylate Cdc25C on its ser216 residue following p14ARF expression, thereby identifying Cdc25C as a new ERK1/2 target. Importantly, we further show that phosphorylation at Ser216 by phospho-ERK1/2 promotes Cdc25C ubiquitination and proteasomal degradation, suggesting that Cdc25C proteolysis is required for a sustained G2 arrest in response to p14ARF. Taken together, these results demonstrate that the MAPK ERK signaling pathway contributes to the p53-independent antiproliferative functions of p14ARF. Furthermore, they identify a new mechanism by which phosphorylation at serine 216 participates to Cdc25C inactivation.
Insights
The p14ARF tumor suppressor triggers a p53-independent G2 arrest by activating ERK1/2 MAP kinases. This pathway phosphorylates Cdc25C at Ser216, leading to its degradation and cell cycle arrest.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- Cdc25C phosphatase regulates mitotic entry, with phosphorylation at Ser216 inducing inactivation via 14-3-3 binding.
- p14ARF, a tumor suppressor, previously shown to induce inactive Cdc25C(Ser216) and p53-independent G2 arrest.
Purpose of the Study:
- Investigate the signaling pathways mediating p14ARF-induced G2 arrest.
- Identify the role of ERK1/2 MAP kinases in this process.
- Determine if Cdc25C is a direct target of ERK1/2.
Main Methods:
- Utilized pharmacological inhibitors to probe signaling pathways.
- Assessed protein levels and phosphorylation status of Cdc25C and ERK1/2.
- Investigated protein-protein interactions and ubiquitination/degradation pathways.
Main Results:
- p14ARF expression activates the ERK1/2 MAP kinase pathway, inducing a p53-independent G2 checkpoint.
- Activated ERK1/2 directly phosphorylates Cdc25C at Ser216, identifying Cdc25C as a novel ERK1/2 target.
- Phosphorylation at Ser216 by ERK1/2 promotes Cdc25C ubiquitination and proteasomal degradation, essential for sustained G2 arrest.
Conclusions:
- The MAPK ERK signaling pathway is crucial for p14ARF's p53-independent antiproliferative functions.
- p14ARF-induced G2 arrest involves ERK1/2-mediated phosphorylation and subsequent degradation of Cdc25C.
- This study reveals a new mechanism for Cdc25C inactivation through Ser216 phosphorylation and proteolysis.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
MAPK Signaling Cascades
Inhibition of Cdk Activity
Anaphase Promoting Complex

